Browse > Article

Lymphatic Delivery of $^{99m}Tc$-labeled Dextran Acetate Particles Including Cyclosporine A  

Kim, Jin (Department of Advanced Chemicals Graduate School, Chonnam National University)
Chung, Kyong-Hwan (Center for Functional Nano Fine Chemicals, Chonnam National University)
Lee, Chang-Moon (Department of Nuclear Medicine and Research Institute of Clinical Medicine, Chonbuk National University School of Medicine)
Seo, Young-Soon (Department of Nuclear Medicine, Chonnam National University Medical School)
Song, Ho-Chun (Department of Nuclear Medicine, Chonnam National University Medical School)
Lee, Ki-Young (Center for Functional Nano Fine Chemicals, Chonnam National University)
Publication Information
Journal of Microbiology and Biotechnology / v.18, no.9, 2008 , pp. 1599-1605 More about this Journal
Abstract
Biodistribution and lymphoscintigraphy of cyclosporine A (CyA) and technetium-99m ($^{99m}Tc$) were studied using ${^99m}Tc$-labeled dextran acetate (DxA) including CyA. DxA particles were prepared from dextran with acetic anhydride, and CyA was loaded into them. Lymphatic delivery of ${^99m}Tc$-labeled DxA particles containing CyA was evaluated after subcutaneous injection into the foot pad of rats and compared with those of ${^99m}Tc$-labeled human serum albumin (HSA). The labeling efficiency of CyA-loaded ${^99m}Tc$-DxA particles was about 95% at 30 min. The labeling efficiency maintained stably above 80% for 12 h. The percent injected dose (%ID) of CyA-loaded ${^99m}Tc$-DxA was similar to that of ${^99m}Tc$-HSA at the inguinal lymph node after 40 min. The CyA-loaded ${^99m}Tc$-DxA could be as well distributed as ${^99m}Tc$-HSA through the lymph node. The DxA particles could steadily distribute the CyA as well as the ${^99m}Tc$ radiolabeling through the lymph node.
Keywords
Dextran acetate; lymphatic delivery; cyclosporine A; technetium-99m labeling; human serum albumin;
Citations & Related Records

Times Cited By Web Of Science : 4  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Albertini, J. J., G. H. Lyman, C. Cox, T. Yeatman, L. Balducci, and N. Ku. 1996. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 11: 1818-1822
2 Bhatnagar, A., A. K. Singh, D. Lahoti, T. Singh, and C. M. Khanna. 1996. Technetium-99m dextran: A promising new proteinlosing enteropathy imaging agent. Eur. J. Nucl. Med. 23: 575-578   DOI   ScienceOn
3 Boinpally, R. R., S. L. Zhou, G. Devraj, P. K. Anne, S. Poondru, and D. R. Jasti. 2004. Iontophoresis of lecithin vesicles of cyclosporine A. Int. J. Pharm. 274: 185-190   DOI
4 Dansereau, R. N. and B. R. Line. 2000. Clinical production of pharmaceutical grade $^{99m}Tc$ dextran 70 for lymphoscintigraphy. Clin. Nucl. Med. 25: 179-181   DOI   ScienceOn
5 Drug Topics.com. http://www.drug-topics.com and search past issues
6 Holm R., C. J. H. Porter, G. A. Edwards, A. Mullertz, H. G. Kristensen, and W. N. Charman. 2003. Examination of oral absorption and lymphatic transport of halofantrine in a triplecannulated canine model after administration in selfmicroemulsifying drug delivery systems (SMEDDS) containing structured triglycerides. Eur. J. Pharm Sci. 20: 91-97   DOI   ScienceOn
7 Kapoor, S., S. K. Ratan, R. Kashyap, S. K. Mittal, K. Rajeshwari, and H. Rawat. 2002. Detecting protein losing enteropathy by $^{99m}Tc$ dextran scintigraphy: A novel experience. Indian J. Pediatr. 69: 761-764   DOI   ScienceOn
8 Kim, C. K., S. A. Ryu, K. M. Park, S. J. Lim, and S. J. Hwang. 1997. Preparation and physicochemical characterization of phase inverted water/oil microemulsion containing CyA. Int. J. Pharm. 147: 131-134   DOI   ScienceOn
9 Matsunaga, K., K. Hara, T. Imamura, T. Fujioka, J. Takata, and Y. Karube. 2005. Technetium labeling of dextran loading cysteamine as a ligand. Nucl. Med. Biol. 32: 279-285   DOI   ScienceOn
10 Miyake, K., H. Arima, T. Irie, F. Hiraayama, and K. Uekama. 1998. Enhanced adsorption of CyA by complexation with dimethyl-beta-cyclodextrin in bile duct cannulated and noncannulated rats. Biol. Pharm. Sci. 22: 66-72
11 Motozato, Y., H. Ihara, T. Tomoda, and C. Hirayama. 1986. Preparation and gel permeation chromatographic properties of pulluan sphere. J. Chromatogr. 335: 434-437
12 Murdan, S., T. Andrysek, and D. Son. 2005. Novel gels and their dispersions-oral drug delivery and systems for cyclosporine. Int. J. Pharm. 300: 113-124   DOI
13 Park, K., W. S. E. Shalaby, and H. Park. 1993. Biodegradable Hydrogels for Drug Delivery. Technomic Publishing Inc., Lancaster
14 Xavier, N. L., B. B. Amaral, C. T. Cerski, S. C. Fuchs, B. L. Spiro, and O. L. Oliveira. 2001. Sentinel lymph node identification and sampling in women with early breast cancer using $^{99m}Tc$ labeled dextran 500 and patent blue V dye. Nucl. Med. Commun. 22: 1109-1117   DOI
15 Lee, C.-M., Y.-J. Heo, H.-C. Song, H.-S. Bom, H.-C. Lee, H.-J. Jeong, and K.-Y. Lee. 2007. Radioevaluation of PAMs, CMs, and PS-Lip as an oral carrier for vaccine delivery into intestinal Peyer's patches. Drug Develop. Res. 67: 1-6
16 McEvoy, G. K. (ed.). 1990. AHFS (American Hospital Formulary Services) Drug Information, pp. 2570-2576. American Society of Health-System Pharmacists, Bethesda, MD
17 Wang, X.-Q., J.-D. Dai, Z. Chen, T. Zhang, G.-M. Xia, T. Nagai, and Q. Zhang. 2004. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. J. Control. Release 97: 421-429   DOI
18 Odeberg, J. M., P. Kaufmann, K. G. Kroon, and P. Hoglund. 2003. Lipid drug delivery and rational formulation design for lipophilic drugs with low oral bioavailability applied to cyclosporine. Eur. J. Pharm. Sci. 20: 375-382   DOI
19 Bhatnagar, A., D. Lahoti, A. K. Singh, L. R. Shankar, B. Sharma, and T. Singh. 1995. Scintigraphic diagnosis of protein losing enteropathy using $^{99m}Tc$ dextran. Clin. Nucl. Med. 20: 1070-1073   DOI
20 Caitriona, M. 2002. Lipid-based formulations for intestinal lymphatic delivery. Eur. J. Pharm. Sci. 15: 405-415   DOI   ScienceOn
21 Marquez, M., J.-E. Westlin, S. Nilson, and A. R. Holmberg. 1996. $^{99m}Tc-dextran$ antibody conjugates. Labeling procedures. Acta Oncol. 35: 489-492   DOI   ScienceOn
22 Chacon, M., J. Molpeceres, L. Berges, M. Guzman, and M. R. Aberturas. 1999. Stability and freeze-drying of cyclosporine loaded poly(D,L-lactide-glycolide) carriers. Eur. J. Pharma. Sci. 8: 99-107   DOI   ScienceOn
23 Gao, Z. G., H. G. Choi, H. J. Shin, K. M. Park, S. J. Lim, K. J. Hwang, and C. K. Kim. 1998. Physicochemical characterization and evauation of a microemulsion system for oral delivery of CyA. Int. J. Pharm. 161: 75-86   DOI   ScienceOn
24 Kao, C.-H., H.-T. Lin, S.-L. Yu, S.-J. Wang, and J.-L. Lan. 1995. Effects of corticosteroid inhalation therapy on the depositopn pattern of Tc-99m human serum albumin radioaerosols in asthma. Lung 173: 291-296
25 Piato, J. R., A. C. Barros, K. M. Pincerato, A. P. Sampaio, and J. A. Pinotti. 2003. Sentinel lymph node biopsy in breast cancer after neoadjuvant chemotherapy. A pilot study. Eur. J. Surg. Oncol. 29: 118-120   DOI   ScienceOn
26 Vigario, A., M. T. Sapienza, A. P. Sampaio, J. R. Piato, N. Barros, and A. Barros. 2003. Primary chemotherapy effect in sentinel node detection in breast cancer. Clin. Nucl. Med. 28: 553-557   DOI   ScienceOn
27 William, N. C. and J. H. P. Christopher. 1996. Lipophilic prodrugs designed for intestinal lymphatic transport. Adv. Drug Deliv. Rev. 19: 149-169   DOI   ScienceOn
28 Tejani, A. 1998. Neoral: The microemulsion formulation. Pediatr. Transplant. 2: 85-86
29 Bhatnagar, A., A. K. Singh, T. Singh, and L. R. Shankar. 1995. $^{99m}Tc-dextran$: A potential inflammation-seeking radiopharmaceutical. Nucl. Med. Commun. 16: 1058-1062   DOI   ScienceOn
30 Neubauer, S., I. Mena, R. Iglesis, R. Schwartz, J. C. Acevedo, and A. Leon. 2001. Sentinel lymph node mapping in melanoma with technetium-99m dextran. Cancer Biother. Radiopharm. 16: 265-267   DOI   ScienceOn
31 Kumar, V. and G. S. Banker. 1996. Target-oriented drug delivery systems, pp. 662-663. In G. S. Banker and C. T. Rhodes (eds.), Modern Pharmaceutics. Marcel Dekker, New York
32 Henze, E., H. R. Schelbert, J. D. Collins, A. Najafi, J. R. Bario, and L. R. Bennett. 1982. Lymphoscintigraphy with 99mTc labelled dextran. J. Nucl. Med. 23: 923-929
33 Wingardh, K. and S.-E. Strand. 1989. Evaluation in vitro and in vivo of two labeling techniques of different $^{99m}Tc-dextrans$ for lymphoscintigraphy. Eur. J. Nucl. Med. 15: 146-151
34 Holmberg, A., M. Marquez, J.-E. Westlin, and S. Nilson. 1995. Labeling of polypeptides with technetium-99m using a dextran spacer. Cancer Res. 55: 5710-5713
35 Dass, R. S., A. K. Singh, and U. P. S. Chauhan. 1993. Development of a dextran kit for labelling with $^{99m}Tc$ and its evaluation for lymphoscintigraphy. Nucl. Med. Biol. 20: 701-706   DOI   ScienceOn
36 Edreira, M. M., L. L. Colombo, J. H. Perez, E. O. Sajaroff, and S. G. de Castiglia. 2001. In vivo evaluation of three different $^{99m}Tc-labeled$ radiopharmaceuticals for sentinel lymph node identification. Nucl. Med. Commun. 22: 499-504   DOI   ScienceOn
37 Guo, J., O. Ping, and Y. Chen. 2001. Pharmacokinetic behavior of cyclosporine A in rabbits by oral administration of lectin vesicle and Sandimmun Neoral. Int. J. Pharmaceut. 216: 17-21   DOI
38 Henze, E., G. G. Robinson, D. E. Kuhl, and H. R. Schelbert. 1982. $^{99m}Tc$ dextran: A new blood-pool labeling agent for radionuclide angiocardiography. J. Nucl. Med. 23: 348-353
39 Drewe, J., C. Beglinger, and T. Kissel. 1992. The absorption site of cyclosporine in the human gastrointestinal tract. Br. J. Clin. Pharmacol. 33: 39-43   DOI   ScienceOn
40 Urata, T., K. Arimori, and H. Nakano. 1999. Modification of release rates of cyclosporine A from poly(L-lactic acid) microspheres by fatty acid esters and in-vivo evaluation of the microspheres. J. Control. Release 58: 133-141   DOI   ScienceOn
41 Wang, X.-Q., J. Huang, J.-D. Dai, T. Zhang, W.-L. Lu, H. Zhang, X. Zhang, J.-C. Wang, and Q. Zhang. 2006. Long-term studies on the stability and oral bioavailability of cyclosporine A nanoparticle colloid. In. J. Pharm. 322: 146-153
42 Bhatnagar, A., A. K. Singh, T. Singh, R. S. Sethi, and N. L. Soni. 1998. Inflammation imaging using $^{99m}Tc$ dextran. Clin. Nucl. Med. 23: 123-124   DOI   ScienceOn
43 Dansereau, R. N. and B. R. Line. 1994. Preparation of dextran 70 injection labeled with technetium 99m for use as a cardiac blood-pool imaging agent. Am. J. Hosp. Pharm. 15: 2797-2800
44 Ercan, M. T., M. Schneidereit, R. Senekowitsch, and H. Kriegel. 1985. Evaluation of $^{99m}Tc$ as a lymphoscintigraphic agent in rabbits. Eur. J. Nucl. Med. 11: 80-84
45 Jeong J. M., M. K. Hong, Y. J. Kim, J. Lee, J. H. Kang, D. S. Lee, J.-K. Chung, and M. C. Lee. 2004. Development of 99mTc-neomannosyl human serum albumin as a novel receptor binding agent for sentinel lymph node imaging. Nucl. Med. Commun. 25: 1211-1217   DOI   ScienceOn